Contribution of 5-hydroxytryptamine1B receptors and 20-hydroxyeiscosatetraenoic acid to fall in cerebral blood flow after subarachnoid hemorrhage

Stroke

Volumn 34, Issue 5, 2003, Pages 1269-1275

  Cambj Sapunar, Liana ^a   Yu, Ming ^a   Harder, David R ^a   Roman, Richard J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Arachidonic acids; Cerebral blood flow; Head injury; Rats; Stroke

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; CALCIUM; ISAMOLTANE; SEROTONIN; SEROTONIN 1B ANTAGONIST; SEROTONIN 1B RECEPTOR; 20 HYDROXY 5,8,11,14 EICOSATETRAENOIC ACID; 20-HYDROXY-5,8,11,14-EICOSATETRAENOIC ACID; AMIDINE; ARACHIDIC ACID; ENZYME INHIBITOR; HYDROXYICOSATETRAENOIC ACID; N HYDROXY N' (4 BUTYL 2 METHYLPHENYL)FORMAMIDINE; N-HYDROXY-N'-(4-BUTYL-2-METHYLPHENYL)FORMAMIDINE; PHOSPHOLIPASE A; PROPANOLAMINE DERIVATIVE; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL BLOOD; ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; CEREBROSPINAL FLUID; CONTROLLED STUDY; MALE; MIDDLE CEREBRAL ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SEROTONIN RELEASE; SUBARACHNOID HEMORRHAGE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; ANIMAL; BIOSYNTHESIS; BLOOD; BRAIN CIRCULATION; BRAIN ISCHEMIA; BRAIN VASOSPASM; CALCIUM SIGNALING; CISTERNA MAGNA; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; INJECTION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VASCULAR RESISTANCE;

AMIDINES; ANIMALS; BLOOD; BRAIN ISCHEMIA; CALCIUM SIGNALING; CEREBROSPINAL FLUID; CEREBROVASCULAR CIRCULATION; CISTERNA MAGNA; EICOSANOIC ACIDS; ENZYME INHIBITORS; HYDROXYEICOSATETRAENOIC ACIDS; INJECTIONS; MALE; MIDDLE CEREBRAL ARTERY; MUSCLE, SMOOTH, VASCULAR; PHOSPHOLIPASES A; PROPANOLAMINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS; SUBARACHNOID HEMORRHAGE; VASCULAR RESISTANCE; VASOCONSTRICTION; VASOSPASM, INTRACRANIAL;

EID: 0038304402     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000065829.45234.69     Document Type: Article

References (38)

1. Hop JW, Rinkel GJ, Algra A, van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke. 1997;28:660-664.
2. Broderick JP, Brott TG, Duldner JE, Tomsick T, Leach A. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke. 1994;25:1342-1347.
3. Crompton MR. Cerebral infarction following the rupture of cerebral berry aneurysms. Brain. 1964;87:263-279.
4. Bederson JB, Germano IM, Guarino L. Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat. Stroke. 1995;26:1086-1091; comment 1091-1092.
5. Delgado TJ, Brismar J, Svendgaard NA. Subarachnoid hemorrhage in the rat: angiography and fluorescence microscopy of the major cerebral arteries. Stroke. 1985;16:595-602.
6. Mursch K, Bransi A, Vatter H, Herrendorf G, Behnke-Mursch J, Kolenda H. Blood flow velocities in middle cerebral artery branches after subarachnoid hemorrhage. J Neuroimaging. 2000;10:157-161.
7. Faraci FM, Heistad DD. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev. 1998;78:53-97.
8. Seifert V, Loffler BM, Zimmermann M, Roux S, Stolke D. Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage: correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. J Neurosurg. 1995;82:55-62.
9. Pickard JD, Walker V, Brandt L, Zygmunt S, Smythe J. Effect of intraventricular haemorrhage and rebleeding following subarachnoid haemorrhage on CSF eicosanoids. Acta Neurochir (Wien). 1994;129:152-157.
10. Saida A, Ito H, Shibuya T, Watanabe Y. Time-course alterations of monoamine levels and cerebral blood flow in brain regions after subarachnoid hemorrhage in rats. Brain Res Bull. 1997;43:69-80.
11. Kehl F, Cambj-Sapunar L, Maier KG, Miyata N, Kametani S, Okamoto H, Hudetz AG, Schulte ML, Zagorac D, Harder DR, Roman RJ. 20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat. Am J Physiol. 2002;282:H1556-H1565.
12. Kehl F, Maier KG, Miyata N, Kametani S, Falck JR, Harder DR, Roman RJ. The 20-HETE antagonist WIT-002 attenuates the acute reduction of cerebral blood flow after subarachnoid hemorrhage (SAH) in the rat. FASEB J. 2002;16:A845. Abstract.
13. Voldby B, Engbaek F, Enevoldsen EM. CSF serotonin concentrations and cerebral arterial spasm in patients with ruptured intracranial aneurysm. Stroke. 1982;13:184-189.
14. Bell WH III, Sundt TM Jr, Nofzinger JD. The response of cortical vessels to serotonin in experimental cerebral infarction. J Neurosurg. 1967;26: 203-212.
15. Boullin DJ, Du Boulay GH, Rogers AT. Aetiology of cerebral arterial spasm following subarachnoid haemorrhage: evidence against a major involvement of 5-hydroxy-tryptamine in the production of acute spasm. Br J Clin Pharmacol. 1978;6:203-215.
16. Okwuasaba FK, Weir BK, Cook DA, Krueger CA. Effects of various intracranial fluids on smooth muscle. Neurosurgery. 1981;9:402-406.
17. Noseworthy TW, Weir B, Boisvert D, Espinosa F, Overton T, Marshal ML. Effect of reserpine-kanamycin treatment on chronic vasospasm after platelet-enriched subarachnoid hemorrhage in primates. Neurosurgery. 1984;14:193-197.
18. Nilsson T, Longmore J, Shaw D, Olesen IJ, Edvinsson L. Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry. Br J Pharmacol. 1999;128:1133-1140.
19. Bouchelet I, Case B, Olivier A, Hamel E. No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery. Br J Pharmacol. 2000; 129:501-508.
20. Singhal AB, Caviness VS, Begleiter AF, Mark EJ, Rordorf G, Koroshetz WJ. Cerebral vasoconstriction and stroke after use of serotonergic drugs. Neurology. 2002;58:130-133.
21. Berg KA, Clarke WP. Regulation of 5-HT(1A) and 5-HT(1B) receptor systems by phospholipid signaling cascades. Brain Res Bull. 2001;56: 471-477.
22. Waldmeier PC, Williams M, Baumann PA, Bischoff S, Sills MA, Neale RF. Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT1 receptor subtypes in the rat brain. Naunyn Schmiedebergs Arch Pharmacol. 1988;337:609-620.
23. Miyata N, Taniguchi K, Seki T, Ishimoto T, Sato-Watanabe M, Yasuda Y, Doi M, Kametani S, Tomishima Y, Uek T, Sato M, Kameo K. HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme. Br J Pharmacol. 2001;133:325-329.
24. Maier KG, Henderson L, Narayanan J, Alonso-Galicia M, Falck JR, Roman RJ. Fluorescent HPLC assay for 20-HETE and other P-450 metabolites of arachidonic acid. Am J Physiol. 2000;279:H863-H871.
25. Pussard E, Guigueno N, Adam O, Giudicelli JF. Validation of HPLC-amperometric detection to measure serotonin in plasma, platelets, whole blood, and urine. Clin Chem. 1996;42:1086-1091.
26. Cipolla MJ, Lessov N, Clark WM, Haley EC Jr. Postischemic attenuation of cerebral artery reactivity is increased in the presence of tissue plasminogen activator. Stroke. 2000;31:940-945.
27. Alonso-Galicia M, Falck JR, Reddy KM, Roman RJ. 20-HETE agonists and antagonists in the renal circulation. Am J Physiol. 1999;277:F790-F796.
28. Yu M, Sun CW, Maier KG, Harder DR, Roman RJ. Mechanism of cGMP contribution to the vasodilator response to NO in rat middle cerebral arteries. Am J Physiol. 2002;282:H1724-H1731.
29. Alonso-Galicia M, Sun CW, Falck JR, Harder DR, Roman RJ. Contribution of 20-HETE to the vasodilator actions of nitric oxide in renal arteries. Am J Physiol. 1998;275:F370-F378.
30. Alonso-Galicia M, Hudetz AG, Shen H, Harder DR, Roman RJ. Contribution of 20-HETE to vasodilator actions of nitric oxide in the cerebral microcirculation. Stroke. 1999;30:2727-2734; comment 2734.
31. Oyekan A, Balazy M, McGiff JC. Renal oxygenases: differential contribution to vasoconstriction induced by ET-1 and ANG II. Am J Physiol. 1997;273:R293-R300.
32. Toyoda K, Farad FM, Watanabe Y, Ueda T, Andresen JJ, Chu Y, Otake S, Heistad DD. Gene transfer of calcitonin gene-related peptide prevents vasoconstriction after subarachnoid hemorrhage. Circ Res. 2000;87:818-824.
33. Zubkov AY, Ogihara K, Tumu P, Mandybur GD, Lewis AI, Parent AD, Zhang JH. Bloody cerebrospinal fluid alters contractility of cultured arteries. Neurol Res. 1999;21:553-558.
34. Mendelow AD, McCalden TA, Hattingh J, Coull A, Rosendorff C, Eidelman BH. Cerebrovascular reactivity and metabolism after subarachnoid hemorrhage in baboons. Stroke. 1981;12:58-65.
35. Nakagomi T, Kassell NF, Sasaki T, Fujiwara S, Lehman RM, Johshita H, Nazar GB, Torner JC. Effect of subarachnoid hemorrhage on endothelium-dependent vasodilation. J Neurosurg. 1987;66: 915-923.
36. Berg KA, Maayani S, Clarke WP. Interactions between effectors linked to serotonin receptors. Ann N Y Acad Sci. 1998;861:111-120.
37. Harder DR. Increased sensitivity of cat cerebral arteries to serotonin upon elevation of transmural pressure. Pflugers Arch. 1988;411:698-700.
38. Gebremedhin D, Lange AR, Lowry TF, Taheri MR, Birks EK, Hudetz AG, Narayanan J, Falck JR, Okamoto H, Roman RJ, Nithipatikom K, Campbell WB, Harder DR. Production of 20-HETE and its role in autoregulation of cerebral blood flow. Circ Res. 2000;87:60-65.